At LUMICKS, our dream is to unlock single-molecule and -cell analysis.
Understanding the root causes of diseases, such as cancer, at the molecular level is one of the greatest scientific challenges of today. Expanding the knowledge of biological processes that are at the basis of diseases is key for prevention and for developing future cures. We aim at creating an environment for researchers to perform high quality, high throughput single-molecule and -cell experiments in the most accessible manner.
Location: United States, Massachusetts, Cambridge
Member count: 201-500
Phone: +31 20 220 0817
Total raised: $93.034408M
Founded date: 2014
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 19.04.2021 | Series D | $93.034408... | - | finsmes.co... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 09.02.2022 | Paris-base... | Investment firm based in Paris... | - | Megha Paul | tech.eu/20... |
| 29.12.2021 | These are ... | Over the last decade, the star... | amsterdam ... | Vishal Sin... | siliconcan... |
| 24.06.2021 | Looking fo... | Amsterdam’s startup ecosystem ... | amsterdam ... | Vishal Sin... | siliconcan... |
| 19.04.2021 | Amsterdam'... | Lumicks, a developer of single... | - | - | pitchbook.... |
| 16.04.2021 | Lumicks Ra... | Lumicks, an Amsterdam, The Net... | Netherland... | - | finsmes.co... |
| 16.04.2021 | Amsterdam-... | With an exponential increase i... | amsterdam ... | Editorial ... | siliconcan... |
| 16.04.2021 | TG Thera... | Gearing up for a battle with... | - | Nicole DeF... | endpts.com... |
| 16.04.2021 | LUMICKS ra... | Amsterdam, the Netherlands – L... | - | - | gildehealt... |
| 27.06.2018 | New partne... | New partnership aims to accele... | - | - | cambridgen... |
| - | Paris-base... | Investment firm based in Paris... | - | Megha Paul | tech.eu/20... |